CC
Callan Capital’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $36.3K | Hold |
12,055
| – | – | ﹤0.01% | 362 |
|
|
2024
Q4 | $30.9K | Hold |
12,055
| – | – | ﹤0.01% | 339 |
|
|
2024
Q3 | $44.8K | Hold |
12,055
| – | – | ﹤0.01% | 346 |
|
|
2024
Q2 | $76.2K | Buy |
12,055
+1,500
| +14% | +$9.48K | 0.01% | 307 |
|
|
2024
Q1 | $56.7K | Hold |
10,555
| – | – | 0.01% | 295 |
|
|
2023
Q4 | $53K | Hold |
10,555
| – | – | 0.01% | 231 |
|
|
2023
Q3 | $17.8K | Buy |
+10,555
| New | +$17.8K | ﹤0.01% | 203 |
|
|
2016
Q4 | – | Sell |
-3,406,405
| Closed | -$26.5M | – | 42 |
|
|
2016
Q3 | $26.5M | Sell |
3,406,405
-356,681
| -9% | -$2.77M | 10.91% | 3 |
|
|
2016
Q2 | $23.4M | Hold |
3,763,086
| – | – | 9.56% | 3 |
|
|
2016
Q1 | $30.9M | Buy |
3,763,086
+38,573
| +1% | +$317K | 12.97% | 3 |
|
|
2015
Q4 | $64.5M | Buy |
3,724,513
+92,052
| +3% | +$1.6M | 25.53% | 1 |
|
|
2015
Q3 | $41.6M | Buy |
+3,632,461
| New | +$41.6M | 22.59% | 1 |
|